Lupus Therapeutics announced the start of a collaboration to conduct three Phase 3 clinical trials testing an investigational therapeutic ianalumab for systemic lupus erythematosus and lupus nephritis ...
Dorfner Anzaplan Commissioned for Complementary Leaching Test Work Route Confirmation and CAPEX Development for the SME ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results